Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2018-05-11 AGM Information
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
Biocartis - 2018 AGM - Minutes (FINAL) (DUT).pdf
AGM Information Classification · 100% confidence The document text explicitly states in the main heading: "NOTULEN VAN DE GEWONE ALGEMENE VERGADERING VAN AANDEELHOUDERS GEHOUDEN OP 11 MEI 2018" (Minutes of the Ordinary General Meeting of Shareholders held on May 11, 2018). The content details the agenda, voting on annual accounts, remuneration reports, and the reappointment/appointment of directors and management compensation, which are all standard items discussed and documented during an Annual General Meeting (AGM). This directly corresponds to the AGM-R (AGM Information) classification.
2018-05-11 Dutch
180424 Biocartis Q1 2018 Business Update_ENG_FINAL.pdf
Earnings Release Classification · 95% confidence The document is a 'Q1 2018 Business Update' press release from Biocartis. It provides a summary of operational highlights, commercial progress, partnership updates, and a high-level cash position (unaudited). It does not constitute a full interim financial report (which would include comprehensive financial statements) nor is it a mere announcement of a report's publication. It functions as a periodic business update, which falls under the 'Earnings Release' (ER) category in this taxonomy as it provides the initial quarterly performance highlights and outlook. Q1 2018
2018-04-26 English
180424 Biocartis Q1 2018 Business Update_NL_FINAL.pdf
Earnings Release Classification · 98% confidence The document is titled "BIOCARTIS Q1 2018 BUSINESS UPDATE" and is explicitly labeled as a "PERSBERICHT GEREGLEMENTEERDE INFORMATIE" (Regulated Information Press Release). It provides key performance indicators (KPIs) for the first quarter (Q1 2018), updates on commercial activities, partnerships, organizational changes (including board composition proposals for the upcoming AGM), and financial highlights (cash position). This format—a press release summarizing period performance, operational milestones, and outlook—is characteristic of an Earnings Release (ER). It is not the full, comprehensive financial report (10-K or IR), nor is it a transcript (CT) or a presentation (IP). The mention of the upcoming AGM and board changes is secondary to the primary purpose of reporting quarterly business performance. Q1 2018
2018-04-26 Dutch
2017 Annual Report (DUT).pdf
Annual Report Classification · 100% confidence The document is titled 'Jaarverslag 2017' (Annual Report 2017) for Biocartis Group. It contains a comprehensive structure including a message from the CEO/Chairman, corporate governance, remuneration reports, consolidated financial statements, and the auditor's report. It is clearly the full annual report rather than an announcement or a summary, as it provides detailed financial data and business analysis for the fiscal year 2017. FY 2017
2018-04-10 Dutch
AGM 2018 - Explanatory Note (DUT) (final).pdf
AGM Information Classification · 100% confidence The document is titled 'TOELICHTING' (Explanatory Note) for a 'GEWONE ALGEMENE VERGADERING' (Ordinary General Meeting) to be held on May 11, 2018. It details the agenda items, which include the review and approval of annual accounts (for the year ended December 31, 2017), discharge of directors and auditors, approval of the remuneration report, and proposals for the reappointment and appointment of directors. This content—providing explanations and proposals for shareholder votes at the AGM—is characteristic of the materials distributed to shareholders ahead of the meeting to inform their voting decisions. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). While it discusses annual reports (10-K items), the document itself is the explanatory material for the meeting, not the full 10-K or the final voting results (DVA).
2018-04-10 Dutch
Statutory accounts Biocartis Group Final version (DUT).pdf
Audit Report / Information Classification · 98% confidence The document is titled "JAARREKENING EN ANDERE OVEREENKOMSTIG HET WETBOEK VAN VENNOOTSCHAPPEN NEER TE LEGGEN DOCUMENTEN" (Annual Accounts and other documents to be filed in accordance with the Companies Code). It explicitly mentions the 'JAARREKENING' (Annual Accounts) approved on 11-05-2018 for the fiscal year ending 31-12-2017. Furthermore, it contains a detailed 'BALANS NA WINSTVERDELING' (Balance Sheet after appropriation of profit) with line items typical of a full annual financial statement, including references to notes (Toel.) and specific accounting codes (Codes). The length (129,080 chars) is substantial, indicating a full report, not just an announcement. Although the text is in Dutch, the structure and content strongly align with a comprehensive annual financial filing, which corresponds to the definition of a 10-K (Annual Report) in the US context, or its local equivalent for comprehensive annual reporting. FY 2017
2018-04-10 Dutch

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.